Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EID2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EID2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DLL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TIMM50 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SUPT5H - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LGALS13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPS16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100129935 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LGALS14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYRK1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FBL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FCGBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on